vision vaccines hiv tuberculosis malaria 
acquired immune deficiency syndrome aids malaria tuberculosis collectively cause five million deaths per year nonetheless eluded conventional vaccine development reason represent one major global public health challenges enter second decade twenty-first century recent trials provided evidence possible develop vaccines can prevent infection human immunodeficiency virus hiv malaria furthermore advances vaccinology including novel adjuvants prime-boost regimes strategies intracellular antigen presentation led progress developing vaccine tuberculosis discuss advances suggest new tools systems biology structure-based antigen design will lead deeper understanding mechanisms protection turn will lead rational vaccine development also argue new innovative approaches clinical trials will accelerate availability vaccines 
